Stocktoria
SUPERNUS PHARMACEUTICALS, INC. SUPN
SUPERNUS PHARMACEUTICALS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 10,392,636 | $278.0M | 18.09% |
| MILLENNIUM MANAGEMENT LLC | 3,853,212 | $179.2M | 6.71% |
| RENAISSANCE TECHNOLOGIES LLC | 1,478,180 | $68.8M | 2.57% |
| CITADEL ADVISORS LLC | 1,419,482 | $66.0M | 2.47% |
| TWO SIGMA INVESTMENTS, LP | 1,184,378 | $55.1M | 2.06% |
| D. E. Shaw & Co., Inc. | 767,668 | $35.7M | 1.34% |
| AQR CAPITAL MANAGEMENT LLC | 88,756 | $4.1M | 0.15% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.